Vol. 2 No. 4 (2013)

Articles

• Gastrointestinal Stromal Tumors Presenting as Surgical Emergencies: A Six-Patient Case Series

  Fazilet Erozgen, Hüseyin Kadioglu, Mehmet Celal Kizilkaya, Muzaffer Akinci, Ahmet Kocakusak, Adnan Hut, Mehmet Gülen, Ömer Güngörür, Rafet Kaplan

   232-236

  • PDF
• Short-Time Outcome of Intraoperative Radiotherapy (IORT): A Study on Side-Effects and Quality of Life in the Treatment of Early Breast Cancer

  Caroline Page, Pierre-Alain Brioschi, Jacques Bernier

   237-245

  • PDF
• Is FLT3 Internal Tandem Duplication an Unfavorable Risk Factor for High Risk Children with Acute Myeloid Leukemia? - Polish Experience

  K. Pawinska-Wasikowska, T. Ksiazek, A. Wieczorek, M. Matysiak, B. Fic-Sikorska, E. Adamkiewicz-Drozynska, L. Maciejka-Kapuscinska, A. Chybicka, K. Potocka, J. Wachowiak, J. Skalska-Sadowska, J. Kowalczyk, B. Wojcik, M. Wysocki, S. Koltan, M. Krawczuk-Rybak, K. Muszynska-Roslan, W. Mlynarski, M. Stolarska, T. Urasinski, E. Kamienska, T. Szczepanski, R. Tomaszewska, G. Sobol-Milejska, A. Mizia-Malarz, G. Karolczyk, J. Pohorecka, M. Wieczorek, I. Karpinska-Derda, W. Balwierz

   246-253

  • PDF
• Disease-Free Remission Exceeding 37 Years in Patients Treated as Children for Acute Leukemia (AL) with Immunotherapy Using Viable (Cryopreserved) Allogeneic Leukemic Cells Pages 254-26

  Tatiana I. Bulycheva, Svetlana A. Mayakova, Simon V. Skurkovich

   254-264

  • PDF
• Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma

  Janet Wangari-Talbot, Elizabeth Hopper-Borge

   265-282

  • PDF
• Weekly Neoadjuvant Ixabepilone on Surgical Feasibility and Clinical Outcomes in Locally Advanced High-Risk Prostate Cancer: A Phase II Clinical Trial

  J.L. Layton, J.F. Renzulli II, A.M. Taber, D. Golijanin, J.E. Collins, H.H. Safran, A.E. Mega

   283-288

  • PDF
• Effects of Nodal Status and Extent of Surgery on Survival in Triple Negative Breast Cancer

  Raafat S. Alameddine, Nagi S. El Saghir, Elias Elias, Ahmad Saleh, Fady B. Geara, Sally Temraz, Ali Shamseddine

   289-296

  • PDF
• Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?

  Zeli Huang, Jiezhan Feng, Shaoen Li, Weihong Wei, Guoyi Zhang, Qiuxia Lu, Yongfeng Wu, Li Lin, Tao Xu

   297-305

  • PDF
• Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance

  Saurabh G. Vispute, Jun-Jiang Chen, Yue-Li Sun, Kamlesh S. Sodani, Satyakam Singh, Yihang Pan, Tanaji Talele, Charles R. Ashby Jr, Zhe-Sheng Chen

   306-317

  • PDF